Physician profile
Nina Smith
NPI 1235190604
$198,659.94
in general payments reported to CMS, 2019-2025
18 companies · $29K in 2025
The $29K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $31K · 2021: $33K · 2022: $29K · 2023: $20K · 2024: $28K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $77K · Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $76,500.00 |
| Food and Beverage | $480.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $169,123.56 | 2019-2025 | |
| Shire North American Group INC | $27,825.00 | 2019 | |
| Smith+Nephew, INC. | $629.37 | 2020-2025 | Collagenase Santyl, Grafix Pl, Versajet |
| Organogenesis INC. | $469.38 | 2020-2025 | Puraply Wound Matrix, Puraply |
| Amgen INC. | $319.60 | 2019 | |
| Novo Nordisk INC | $52.99 | 2019 | |
| Merck Sharp & Dohme LLC | $29.70 | 2019 | |
| Astellas Pharma US INC | $27.85 | 2019 | |
| Abbvie INC. | $24.08 | 2019 | |
| Kci USA, INC. | $23.83 | 2023 | V.A.C. Dermatac, Activ.A.C., Promogran |
| Convatec INC. | $22.63 | 2023 | |
| Integra Lifesciences Corporation | $19.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.94 | 2019 | |
| Therapeuticsmd, INC. | $16.16 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.13 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $15.73 | 2025 | Urgok2 |
| Misonix INC | $14.42 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.